Paul de Laat

742 total citations
21 papers, 554 citations indexed

About

Paul de Laat is a scholar working on Molecular Biology, Clinical Biochemistry and Rheumatology. According to data from OpenAlex, Paul de Laat has authored 21 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 4 papers in Rheumatology. Recurrent topics in Paul de Laat's work include Mitochondrial Function and Pathology (15 papers), Metabolism and Genetic Disorders (10 papers) and ATP Synthase and ATPases Research (9 papers). Paul de Laat is often cited by papers focused on Mitochondrial Function and Pathology (15 papers), Metabolism and Genetic Disorders (10 papers) and ATP Synthase and ATPases Research (9 papers). Paul de Laat collaborates with scholars based in Netherlands, Israel and United Kingdom. Paul de Laat's co-authors include Jan Smeıtınk, Mirian C. H. Janssen, Saskia Koene, Richard J. Rodenburg, Coriene E. Catsman‐Berrevoets, Annick S. Devos, Marry M. van den Heuvel‐Eibrink, M.L. te Winkel, Rob Pieters and Jan E.E. Keunen and has published in prestigious journals such as Neurology, Ophthalmology and Annals of Oncology.

In The Last Decade

Paul de Laat

21 papers receiving 544 citations

Peers

Paul de Laat

RHEUM

PMH

PPCH

Joyce A. Kobori United States

Hana Vlášková Czechia

Khalid Al‐Thihli Oman

Maria Cristina Schiaffino Italy

Merçè Pineda Spain

Ivana Pela Italy

Miriam Rigoldi Italy

Maria Halldin Sweden

Renata C. Gallagher United States

Stephanie J. DeWard United States

Joyce A. Kobori United States

Paul de Laat

277 ×0.7

234 ×1.0

178 ×1.8

RHEUM

38 ×0.4

PMH

126 ×1.7

PPCH

Citations per year, relative to Paul de Laat Paul de Laat (= 1×) peers Joyce A. Kobori

Countries citing papers authored by Paul de Laat

Since Specialization

Citations

This map shows the geographic impact of Paul de Laat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul de Laat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul de Laat more than expected).

Fields of papers citing papers by Paul de Laat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul de Laat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul de Laat. The network helps show where Paul de Laat may publish in the future.

Co-authorship network of co-authors of Paul de Laat

This figure shows the co-authorship network connecting the top 25 collaborators of Paul de Laat. A scholar is included among the top collaborators of Paul de Laat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul de Laat. Paul de Laat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verhaak, C.M., et al.. (2022). Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant. Journal of Inherited Metabolic Disease. 45(6). 1130–1142. 3 indexed citations

Lindeque, Jeremie Zander, Shayne Mason, Francois H. van der Westhuizen, et al.. (2021). One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation. Metabolomics. 17(1). 10–10. 16 indexed citations

Laat, Paul de, Richard J. Rodenburg, Nel Roeleveld, et al.. (2020). Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variant. Journal of Medical Genetics. 58(1). 48–55. 19 indexed citations

Laat, Paul de, et al.. (2019). Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature. Clinical Kidney Journal. 12(6). 840–846. 15 indexed citations

Custers, José A. E., Paul de Laat, Saskia Koene, et al.. (2018). Fear of disease progression in carriers of the m.3243A > G mutation. Orphanet Journal of Rare Diseases. 13(1). 203–203. 8 indexed citations

Lindeque, Jeremie Zander, Shayne Mason, Francois H. van der Westhuizen, et al.. (2018). A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS). Mitochondrion. 45. 38–45. 16 indexed citations

Laat, Paul de, Richard J. Rodenburg, Jan Smeıtınk, & Mirian C. H. Janssen. (2018). Intra‐patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation. Molecular Genetics & Genomic Medicine. 7(2). e00523–e00523. 12 indexed citations

Koene, Saskia, et al.. (2017). Quantification of gait in mitochondrial m.3243A > G patients: a validation study. Orphanet Journal of Rare Diseases. 12(1). 91–91. 4 indexed citations

Koene, Saskia, Jean‐Pierre Timmermans, Gert Weijers, et al.. (2017). Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? — a retrospective pilot study. Journal of Inherited Metabolic Disease. 40(2). 247–259. 3 indexed citations

10.

Verhaak, C.M., Paul de Laat, Saskia Koene, et al.. (2016). Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation. Orphanet Journal of Rare Diseases. 11(1). 25–25. 14 indexed citations

11.

Laat, Paul de, Mirian C. H. Janssen, Charlotte L. Alston, et al.. (2016). Three families with ‘de novo’ m.3243A>G mutation. PubMed. 6. 19–24. 14 indexed citations

12.

Laat, Paul de, et al.. (2015). Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. Mitochondrion. 25. 98–103. 28 indexed citations

13.

Koene, Saskia, Paul de Laat, Gert Weijers, et al.. (2015). Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers. JIMD Reports. 24. 69–81. 34 indexed citations

14.

Laat, Paul de, H. Zweers, Simone Knuijt, et al.. (2015). Dysphagia, malnutrition and gastrointestinal problems in patients with mitochondrial disease caused by the m3243A>G mutation.. PubMed. 73(1). 30–6. 23 indexed citations

15.

Laat, Paul de, et al.. (2015). Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves’ disease. Journal of Pediatric Endocrinology and Metabolism. 28(9-10). 1169–71. 2 indexed citations

16.

Koene, Saskia, Paul de Laat, Dennis Vriens, et al.. (2014). Serum FGF21 levels in adult m.3243A>G carriers. Neurology. 83(2). 125–133. 31 indexed citations

17.

Laat, Paul de, Jan Smeıtınk, Mirian C. H. Janssen, Jan E.E. Keunen, & Camiel J.F. Boon. (2013). Mitochondrial Retinal Dystrophy Associated with the m.3243A>G Mutation. Ophthalmology. 120(12). 2684–2696. 61 indexed citations

18.

Laat, Paul de, et al.. (2012). Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation. Journal of Inherited Metabolic Disease. 35(6). 1059–1069. 105 indexed citations

19.

Laat, Paul de, et al.. (2012). Inheritance of the m.3243A>G mutation. JIMD Reports. 8. 47–50. 17 indexed citations

20.

Laat, Paul de, M.L. te Winkel, Annick S. Devos, et al.. (2010). Posterior reversible encephalopathy syndrome in childhood cancer. Annals of Oncology. 22(2). 472–478. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact